Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Net Income towards Common Stockholders (2023 - 2025)

Guardian Pharmacy Services' Net Income towards Common Stockholders history spans 3 years, with the latest figure at $21.3 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 79.59% year-over-year to $21.3 million; the TTM value through Dec 2025 reached $49.0 million, up 168.92%, while the annual FY2025 figure was $49.0 million, 168.92% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $21.3 million at Guardian Pharmacy Services, up from $9.6 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $21.3 million in Q4 2025 and bottomed at -$105.8 million in Q3 2024.
  • The 3-year median for Net Income towards Common Stockholders is $9.6 million (2025), against an average of -$835111.1.
  • The largest YoY upside for Net Income towards Common Stockholders was 109.07% in 2025 against a maximum downside of 44.3% in 2025.
  • A 3-year view of Net Income towards Common Stockholders shows it stood at $14.6 million in 2023, then fell by 18.67% to $11.8 million in 2024, then surged by 79.59% to $21.3 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Net Income towards Common Stockholders are $21.3 million (Q4 2025), $9.6 million (Q3 2025), and $8.8 million (Q2 2025).